comparemela.com

Latest Breaking News On - Uncontrolled hypertension - Page 8 : comparemela.com

Palatin Issued Patent on Vyleesi® (Bremelanotide Injection) For Hypoactive Sexual Desire Disorder in Patients With Controlled Hypertension

/PRNewswire/ Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on molecules that.

China
Kwangdong
Ch-ungch-ong-bukto
South-korea
United-states
American
Carl-spana
Fosun-pharma
Trademark-office
Kwangdong-pharmaceuticals
Prnewswire-palatin-technologies-inc
United-states-patent

Palatin Technologies Says USPTO Issues Patent On Vyleesi For Hypoactive Sexual Desire Disorder

(RTTNews) - Biopharmaceutical company Palatin Technologies, Inc. (PTN) announced Tuesday that the United States Patent and Trademark Office issued.

United-states
Trademark-office
Palatin-technologies-inc
Palatin-technologies
United-states-patent
Uncontrolled-hypertension

vimarsana © 2020. All Rights Reserved.